Injectable fomepizole [`Antizol'; Paladin Labs] has been granted priority review status in Canada

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1225, 2000-01, pp. : 23-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GlaxoSmithKline has been granted priority review status in Japan for adefovir dipivoxil [Hepsera; licensed from Gilead Sciences]

Inpharma, Vol. 1, Iss. 1437, 2004-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Schering-Plough's peginterferon (PEG IFN)- -2b plus ribavirin [Peg-Intron plus Rebetol] has been granted priority review status in Japan for a new indication

Inpharma, Vol. 1, Iss. 1495, 2005-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Health Canada has approved ethinylestradiol/levonorgestrel 0.03mg/0.15mg tablets [Seasonale; Paladin Labs] for contraception.

Inpharma, Vol. 1, Iss. 1596, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Pfizer's SU 11248 has been granted orphan drug status by the European Commission

Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

The US FDA has granted priority review for bortezomib [Velcade] for the treatment of patients with newly diagnosed multiple myeloma (MM).

Inpharma, Vol. 1, Iss. 1624, 2008-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite